Topoisomerase II alpha Antikörper
Kurzübersicht für Topoisomerase II alpha Antikörper (ABIN6251852)
Target
Alle Topoisomerase II alpha (TOP2A) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Aufreinigung
- Protein G affinity chromatography
-
Immunogen
- Human partial recombinant protein was used as the immunogen for this Topoisomerase II alpha antibody.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Flow Cytometry: 0.5-1 μg/10^6 cells
IF: 1-2 μg/mL
Western blot: 1-2 μg/mL
IHC (FFPE): 0.5-1 μg/mL (1)
The concentration stated for each application is a general starting point. Variations in protocols, secondaries and substrates may require the Topoisomerase II alpha antibody to be titered up or down for optimal performance.1. Staining of FFPE tissue requires boiling sections in 10 mM citrate buffer, pH 6, for 10-20 min followed by cooling at RT for 20 min.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.2 mg/mL
-
Buffer
- PBS with 0.1 mg/mL BSA and 0.05 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Aliquot and Store at -20C. Avoid freez-thaw cycles.
-
-
- Topoisomerase II alpha (TOP2A) (Topoisomerase (DNA) II alpha 170kDa (TOP2A))
-
Andere Bezeichnung
- Topoisomerase II alpha
-
Hintergrund
- This mAb recognizes a 170 kDa protein which is identified as Topoisomerase IIa, and shows no cross-reaction with Topoisomerase IIb or I. Topo IIa plays important roles in synthesis and transcription of DNA as well as chromosomal segregation during mitosis. It is reported to be a sensitive and specific marker of late S-, G2- & M-phases in transformed and developmentally regulated normal cells. Topo IIa is also implicated in drug resistance of tumor cells.
-
Gen-ID
- 7153
-
UniProt
- P11388
-
Pathways
- Zellzyklus, Mitotic G1-G1/S Phases
Target
-